Federal officials said Monday they're taking a hard look at a new Indiana law that withholds some public funding for Planned Parenthood of Indiana, a development that could cost the state some of its Medicaid funding.
Eli Lilly and Co. has agreed to license the U.S. marketing rights of its slow-selling sepsis drug Xigris to a newly created local biotech company called BioCritica that will seek to reinvigorate sales of the medication.
OrthoIndy, the physician practice that owns the Indiana Orthopaedic Hospital, was able to open a new outpatient facility this spring by working around growth restrictions in the 2010 health care reform law. But its choices for further growth are much starker—which is why it’s lobbying to repeal that provision of the law.
Indiana University Health is now quietly unwinding the physician ownership of its hospitals in Carmel and Avon—which sparked loud controversy when they opened in 2004 and 2005.
U.S. insurers led by WellPoint Inc. and UnitedHealth Group Inc. failed to get federal regulators to change a rule in the 2010 health-care overhaul that triggers a review of any premium increases exceeding 10 percent.
Visiting Nurse Service Inc., a 200-employee agency based in Indianapolis, will operate under the umbrella of Franciscan St. Francis Health, the organizations announced Thursday.
Dan Fink, who joined Riley Hospital for Children nearly six years ago, will depart Friday. Marilyn Cox will serve as interim president and CEO while Riley conducts a national search for a new leader.
The annual growth rate in spending on drugs may be cut in half over the next five years as people opt for less expensive generic medicines over brand-name treatments, a health-care research group said Wednesday, highlighting the challenge pharmaceutical firms like Eli Lilly and Co. are facing.
How can practicing medicine prepare you for a CEO post? And why is it smart to continue seeing patients once you get the top job? Dr. Lisa Harris will see you now with answers.
Shareholders of WellPoint Inc. approved on Tuesday the hefty pay packages of the company’s executives and voted for the right to weigh in annually on future executive compensation.
Prescription drugs are playing an increasing role in the drug-related crimes that are filling up Indiana's prisons, prison officials and prosecutors said.
Amylin Pharmaceuticals Inc. said Monday it filed a lawsuit against Eli Lilly and Co., accusing the larger drugmaker of breaking their commercialization deal for diabetes drugs by teaming with the German company Boehringer Ingelheim to develop and sell a competing product.
Increasing government involvement in the health insurance market will have the counter-intuitive effect of making the industry more consumer-driven, concludes a new report from a health care venture-capital firm.
Warsaw-based Zimmer Holdings Inc. has enjoyed eight years as the giant in the industry of selling knee- and hip-replacement implants to hospitals. But now it faces a challenge from Johnson & Johnson.
Indianapolis-based firm avoided investment losses suffered by peers during last recession.
Is it finally time to get some growth again out of a stock that since its debut on the public market 59 years ago has minted thousands of millionaires?
The operator of the building at 8424 Naab Road near St. Vincent Hospital is accused of owing an Illinois investment firm $4 million.
Some health care system are finally allowing online scheduling.
The problem is, too many people make unhealthy choices and the consequences of these choices become everyone’s problem.
